FDA Drug Application (205040) for RITONAVIR by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number205040
Product Number001
FormTABLET; ORAL
Dosage25MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRITONAVIR
Active IngredientRITONAVIR

Active IngredientCount
List of drugs with Active Ingredient RITONAVIR11


Back to FDA Applications sponsored by CIPLA LIMITED